gallbladder cancer (Cancer)
Information
- Disease name
- gallbladder cancer
- Disease ID
- DOID:3121
- Description
- "A biliary tract cancer that is located_in the gallbladder." [url:http\://en.wikipedia.org/wiki/Gallbladder]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06232538 | Active, not recruiting | UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-up | January 1, 2024 | August 2026 | |
| NCT04383210 | Active, not recruiting | Phase 2 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | September 29, 2020 | March 2025 |
| NCT04308174 | Active, not recruiting | Phase 2 | Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer | May 20, 2020 | December 30, 2024 |
| NCT06223061 | Active, not recruiting | Global Evaluation of Cholecystectomy Knowledge and Outcomes | July 31, 2023 | November 1, 2024 | |
| NCT02293954 | Active, not recruiting | N/A | Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer | November 11, 2015 | December 30, 2024 |
| NCT00003923 | Completed | Phase 2 | Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas | March 1999 | February 2002 |
| NCT00004604 | Completed | Phase 1 | Biological Therapy in Treating Patients With Metastatic Cancer | February 1997 | July 2002 |
| NCT00005938 | Completed | Phase 2 | DX-8951f in Treating Patients With Biliary Cancer | March 2000 | April 2005 |
| NCT00009893 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | May 2001 | October 2009 |
| NCT00019513 | Completed | Phase 1 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | August 1998 | June 2004 |
| NCT00027534 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | January 2002 | October 2007 |
| NCT00033540 | Completed | Phase 2 | S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma | September 2003 | July 2011 |
| NCT00059865 | Completed | Phase 1/Phase 2 | Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer | January 2004 | February 2008 |
| NCT00073905 | Completed | Phase 2 | Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer | April 2003 | January 2009 |
| NCT00084942 | Completed | Phase 2 | Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder | October 2002 | November 2006 |
| NCT00123825 | Completed | Phase 2 | Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer | July 2002 | October 2007 |
| NCT00262769 | Completed | Phase 3 | Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors | May 2005 | |
| NCT00266097 | Completed | Phase 1 | Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer | August 2004 | September 2011 |
| NCT00280709 | Completed | Phase 4 | Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction | January 2006 | August 2010 |
| NCT00304135 | Completed | Phase 2/Phase 3 | Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery | October 2005 | December 2012 |
| NCT00350753 | Completed | Phase 2 | Avastin and Tarceva for Upper Gastrointestinal Cancers | June 2006 | June 2009 |
| NCT00363584 | Completed | Phase 3 | Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer | March 2006 | |
| NCT00391183 | Completed | Phase 2/Phase 3 | Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block. | January 2006 | December 2012 |
| NCT00003276 | Completed | Phase 2 | Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer | March 1998 | March 2001 |
| NCT00003411 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | November 1998 | June 2002 |
| NCT00003427 | Completed | Phase 1 | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | April 1998 | April 2002 |
| NCT00003557 | Completed | Phase 2 | Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer | January 1999 | August 2003 |
| NCT00003046 | Completed | Phase 1 | Interleukin-12 in Treating Patients With Cancer in the Abdomen | August 1997 | October 2001 |
| NCT00409864 | Completed | N/A | Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer | October 2003 | December 2005 |
| NCT00423254 | Completed | Phase 1 | Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. | February 2007 | November 2009 |
| NCT00486356 | Completed | Phase 1 | Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer | October 1, 2004 | January 1, 2010 |
| NCT00489515 | Completed | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | February 1999 | August 2010 | |
| NCT00513539 | Completed | Phase 3 | Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery | July 2007 | |
| NCT00544193 | Completed | Phase 1 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | December 1997 | August 2012 |
| NCT00579865 | Completed | Quality Of Life in Patients With Malignant Biliary Obstruction | May 2005 | January 2010 | |
| NCT00654160 | Completed | Phase 1 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | June 2008 | December 3, 2012 |
| NCT00660140 | Completed | Phase 2 | Study of Gemcitabine and Carboplatin in the Treatment of Metastatic or Recurrent Cholangiocarcinoma/Gallbladder Cancer | March 2002 | April 2009 |
| NCT00660699 | Completed | Phase 2 | A Feasibility Phase II Study in the Treatment of Resected Cholangiocarcinoma, Gallbladder, Pancreatic and Ampullary Cancers | September 2002 | September 2012 |
| NCT00753675 | Completed | Phase 2 | Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer | October 2008 | September 2012 |
| NCT00789958 | Completed | Phase 2 | S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct | December 2008 | December 2017 |
| NCT00836992 | Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | January 2009 | July 27, 2015 | |
| NCT00919061 | Completed | Phase 2 | Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy | August 2009 | March 2014 |
| NCT00987766 | Completed | Phase 1 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | November 2009 | October 2016 |
| NCT01308840 | Completed | Phase 2 | Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer | December 2010 | January 2013 |
| NCT01313377 | Completed | Phase 3 | Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery | July 2009 | June 2016 |
| NCT01320241 | Completed | Phase 2 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | November 2008 | March 2012 |
| NCT01640522 | Completed | N/A | Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | January 2008 | December 2014 |
| NCT01926236 | Completed | Phase 3 | Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers | February 2014 | January 2019 |
| NCT02326948 | Completed | Alcohol Consumption and Gallbladder Cancer | August 2014 | November 2014 | |
| NCT02351765 | Completed | Phase 1 | ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers | January 2016 | March 2019 |
| NCT02489422 | Completed | N/A | Programs To Support You During Chemotherapy | August 2016 | January 2020 |
| NCT02692911 | Completed | Chile Biliary Longitudinal Study | January 11, 2017 | June 15, 2020 | |
| NCT02778308 | Completed | N/A | Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma | January 2012 | December 2018 |
| NCT03111732 | Completed | Phase 2 | Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) | June 14, 2017 | November 8, 2021 |
| NCT03260712 | Completed | Phase 2 | Pembrolizumab in Biliary Tract Cancer | January 7, 2020 | August 31, 2023 |
| NCT03833661 | Completed | Phase 2 | M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) | March 26, 2019 | September 30, 2022 |
| NCT04534309 | Completed | N/A | Behavioral Weight Loss Program for Cancer Survivors in Maryland | September 22, 2020 | June 30, 2023 |
| NCT04742959 | Completed | Phase 1/Phase 2 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | March 14, 2021 | February 20, 2024 |
| NCT05559229 | Completed | Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Level of Alpha-fetoprotein: a Case Report | January 15, 2021 | September 18, 2022 | |
| NCT06189664 | Completed | Evaluation of the Effectiveness of Intraoperative Frozen Section on the Treatment of Suspected Gallbladder Cancer | January 1, 2013 | December 31, 2020 | |
| NCT06061744 | Enrolling by invitation | Robot-assisted vs Laparoscopic vs Open Radical Cholecystectomy for Gallbladder Cancer | April 1, 2023 | January 30, 2024 | |
| NCT06134193 | Not yet recruiting | Phase 2 | Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer | November 2023 | June 2025 |
| NCT06276153 | Not yet recruiting | Construction of Multicenter Retrospective Registry Cohort Database for Gallbladder Cancer | March 1, 2024 | February 28, 2029 | |
| NCT05896956 | Not yet recruiting | The Construction of Clinical Database and Multiomics Biobank Based on a Multicentral Prospective Cohort of Benign and Malignant Biliary Tract Diseases | July 1, 2023 | June 30, 2027 | |
| NCT04871321 | Recruiting | Biomarker Discovery in Patients With Advanced Biliary Tract Cancer | April 14, 2021 | December 31, 2024 | |
| NCT05718115 | Recruiting | Deep Learning Radiogenomics For Individualized Therapy in Unresectable Gallbladder Cancer | February 15, 2023 | December 31, 2023 | |
| NCT02920554 | Recruiting | N/A | The Effect in Wedge Resection and IVb/V Resection of the Liver for Gallbladder Cancer | July 2014 | December 2030 |
| NCT06123117 | Recruiting | N/A | STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy | January 16, 2024 | October 2027 |
| NCT05712356 | Recruiting | Phase 2 | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | August 24, 2023 | December 2025 |
| NCT05596370 | Recruiting | Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer | January 6, 2022 | December 31, 2024 | |
| NCT03637569 | Recruiting | The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer | April 1, 2018 | December 31, 2026 | |
| NCT05489250 | Recruiting | The PLATON Network | October 28, 2020 | May 31, 2032 | |
| NCT05404347 | Recruiting | NGS in Gallbladder Cancer and Response to Treatment | January 1, 2018 | December 31, 2025 | |
| NCT04104230 | Recruiting | Quebec Pancreas Cancer Study | March 12, 2012 | January 2025 | |
| NCT05253053 | Recruiting | Phase 1/Phase 2 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | April 13, 2022 | December 2024 |
| NCT05757336 | Recruiting | Phase 2 | Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer | December 22, 2022 | December 22, 2026 |
| NCT05833815 | Recruiting | Phase 2/Phase 3 | Addition of Everolimus to Standard of Care in Carcinoma Gallbladder | November 1, 2022 | November 30, 2023 |
| NCT05184400 | Recruiting | Identification of New Biomarkers for Patients With Cholangiocarcinoma and Gallbladder Cancer | January 1, 2015 | December 31, 2030 | |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT04362449 | Recruiting | Phase 2 | Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration | January 2, 2019 | February 2, 2023 |
| NCT06013943 | Recruiting | Phase 2 | Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC | March 17, 2023 | December 2025 |
| NCT04484636 | Recruiting | N/A | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) | October 28, 2020 | July 30, 2024 |
| NCT04445532 | Recruiting | Hepatobiliary Tumors Tissue Samples Acquisition | October 11, 2020 | June 1, 2025 | |
| NCT06192719 | Recruiting | EULAT Eradicate GBC | December 1, 2019 | December 31, 2028 | |
| NCT04561453 | Recruiting | Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer | July 8, 2020 | July 1, 2025 | |
| NCT04907643 | Recruiting | N/A | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | October 5, 2021 | March 2026 |
| NCT00903396 | Terminated | Phase 2 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | September 2009 | May 2013 |
| NCT04066491 | Terminated | Phase 2/Phase 3 | Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC | September 20, 2019 | November 10, 2022 |
| NCT00387348 | Terminated | Phase 3 | Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer | March 2006 | April 2011 |
| NCT00414843 | Terminated | Storage of Bile From Routine Procedures to Study Risk Factors | December 2006 | August 2015 | |
| NCT00012246 | Terminated | Phase 2 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | July 2002 | July 2006 |
| NCT00658593 | Terminated | Phase 3 | Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer | October 10, 2008 | January 18, 2011 |
| NCT00005997 | Terminated | Phase 2 | Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer | April 1999 | November 2005 |
| NCT00832637 | Terminated | Phase 2 | Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | August 2007 | March 15, 2017 |
| NCT00896467 | Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | September 2007 | November 2010 | |
| NCT00955721 | Terminated | Phase 1/Phase 2 | A Study of Combination of Gemcitabine, Oxaliplatin (GEMOX)-Sorafenib in Patients With Advanced Biliary Tract Cancer | August 2009 | July 2014 |
| NCT04337333 | Unknown status | N/A | Two-in-one Covered and Uncovered Metal Stent | May 1, 2016 | December 31, 2021 |
| NCT05237193 | Unknown status | A Prospective Study of UCAD for Diagnosing Benign or Malignant Biliary Obstruction and Follow-up | September 3, 2021 | March 2024 | |
| NCT04637048 | Unknown status | Observational Study on Patients With Hepatobiliary Tumors | February 16, 2017 | December 1, 2023 | |
| NCT02662348 | Unknown status | Phase 1 | T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System | February 2016 | November 2017 |
| NCT04333927 | Unknown status | Phase 2 | Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer | June 1, 2020 | June 2024 |
| NCT00356161 | Unknown status | Phase 2 | HAI Via Interventionally Implanted Port Catheter Systems | April 2002 | April 2008 |
| NCT02659852 | Unknown status | N/A | A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction | January 2016 | January 2020 |
| NCT03772132 | Unknown status | Phase 2 | Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | July 2016 | December 2021 |
| NCT03768375 | Unknown status | Phase 2 | Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | November 2016 | December 30, 2021 |
| NCT00003296 | Unknown status | Phase 2 | Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer | January 1998 | |
| NCT01317069 | Unknown status | Phase 2 | A Randomized, Open, Prospective Clinical Research of Fluorouracil Implant to Improve Surgical Gallbladder Cancer and Bile Duct Cancer | June 2010 | April 2013 |
| NCT03491878 | Unknown status | N/A | Three Dimension Laparoscopic Versus Open Surgery for Gallbladder Carcinoma | May 1, 2018 | May 1, 2022 |
| NCT03210298 | Unknown status | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | January 2016 | September 2022 | |
| NCT02836847 | Unknown status | Phase 2 | Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma | July 2016 | December 2020 |
| NCT00386516 | Withdrawn | Phase 2 | Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer | September 2006 | June 2009 |
| NCT00588263 | Withdrawn | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer | July 2000 | July 2018 |
- Disase is a (Disease Ontology)
- DOID:4607
- Cross Reference ID (Disease Ontology)
- GARD:9328
- Cross Reference ID (Disease Ontology)
- ICD10CM:C23
- Cross Reference ID (Disease Ontology)
- ICD9CM:156.0
- Cross Reference ID (Disease Ontology)
- MESH:D005706
- Cross Reference ID (Disease Ontology)
- NCI:C3048
- Cross Reference ID (Disease Ontology)
- NCI:C35676
- Cross Reference ID (Disease Ontology)
- NCI:C7481
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126854002
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93810008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0016978
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153452
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0278806
- Exact Synonym (Disease Ontology)
- gallbladder Ca
- Exact Synonym (Disease Ontology)
- gallbladder neoplasm
- Exact Synonym (Disease Ontology)
- localized malignant gallbladder neoplasm
- Exact Synonym (Disease Ontology)
- malignant neoplasm of gallbladder
- Exact Synonym (Disease Ontology)
- malignant tumor of the gallbladder
- Exact Synonym (Disease Ontology)
- malignant tumour of gallbladder
- Exact Synonym (Disease Ontology)
- tumor of the gallbladder